Stelios Bouralexis

1000 total citations
13 papers, 845 citations indexed

About

Stelios Bouralexis is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Stelios Bouralexis has authored 13 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Stelios Bouralexis's work include Cell death mechanisms and regulation (7 papers), NF-κB Signaling Pathways (6 papers) and Bone Metabolism and Diseases (4 papers). Stelios Bouralexis is often cited by papers focused on Cell death mechanisms and regulation (7 papers), NF-κB Signaling Pathways (6 papers) and Bone Metabolism and Diseases (4 papers). Stelios Bouralexis collaborates with scholars based in Australia and United Kingdom. Stelios Bouralexis's co-authors include Andreas Evdokiou, David M. Findlay, Shelley Hay, Gerald J. Atkins, David R. Haynes, Agatha Labrinidis, Stephen E. Graves, Mark Clayer, Andrew C.W. Zannettino and Fugui Chai and has published in prestigious journals such as The Journal of Immunology, British Journal of Cancer and Journal of Bone and Mineral Research.

In The Last Decade

Stelios Bouralexis

13 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stelios Bouralexis Australia	13	573	332	189	179	161	13	845
Hassan Adwan Germany	18	390 0.7×	424 1.3×	187 1.0×	190 1.1×	133 0.8×	32	910
K. Yamaguchi Japan	10	835 1.5×	591 1.8×	143 0.8×	83 0.5×	144 0.9×	22	1.2k
Adelheid Munz Germany	18	278 0.5×	321 1.0×	72 0.4×	81 0.5×	234 1.5×	31	724
P.R. Elford Switzerland	18	678 1.2×	448 1.3×	321 1.7×	241 1.3×	119 0.7×	24	1.2k
John R. Spaull United Kingdom	14	208 0.4×	334 1.0×	281 1.5×	134 0.7×	120 0.7×	17	878
Edgardo Salvatierra Argentina	12	252 0.4×	239 0.7×	240 1.3×	64 0.4×	98 0.6×	15	635
Jumpei Teramachi Japan	17	368 0.6×	228 0.7×	67 0.4×	64 0.4×	90 0.6×	45	622
Yasutaka Hayashido Japan	17	344 0.6×	269 0.8×	67 0.4×	42 0.2×	164 1.0×	47	780
Rasesh Kapadia United States	13	612 1.1×	428 1.3×	320 1.7×	94 0.5×	154 1.0×	15	1.0k
Joseph L. Sottnik United States	17	342 0.6×	341 1.0×	35 0.2×	105 0.6×	163 1.0×	26	837

Countries citing papers authored by Stelios Bouralexis

Since Specialization

Citations

This map shows the geographic impact of Stelios Bouralexis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stelios Bouralexis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stelios Bouralexis more than expected).

Fields of papers citing papers by Stelios Bouralexis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stelios Bouralexis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stelios Bouralexis. The network helps show where Stelios Bouralexis may publish in the future.

Co-authorship network of co-authors of Stelios Bouralexis

This figure shows the co-authorship network connecting the top 25 collaborators of Stelios Bouralexis. A scholar is included among the top collaborators of Stelios Bouralexis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stelios Bouralexis. Stelios Bouralexis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Quinn, J, Natalie A. Sims, Keith Thompson, et al.. (2008). IL-23 Inhibits Osteoclastogenesis Indirectly through Lymphocytes and Is Required for the Maintenance of Bone Mass in Mice. The Journal of Immunology. 181(8). 5720–5729. 77 indexed citations

Nakamura, Akira, Chi Ly, Natalie A. Sims, et al.. (2007). Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro. Bone. 40(2). 305–315. 29 indexed citations

Butler, Lisa M., Vasilios Liapis, Stelios Bouralexis, et al.. (2006). The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL. International Journal of Cancer. 119(4). 944–954. 62 indexed citations

Bouralexis, Stelios, David M. Findlay, & Andreas Evdokiou. (2005). Death to the bad guys: Targeting cancer via Apo2L/TRAIL. APOPTOSIS. 10(1). 35–51. 107 indexed citations

Bouralexis, Stelios, Mark Clayer, Gerald J. Atkins, et al.. (2004). Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin. International Journal of Oncology. 24(5). 1263–70. 13 indexed citations

Evdokiou, Andreas, Agatha Labrinidis, Stelios Bouralexis, Shelley Hay, & David M. Findlay. (2003). Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis. Bone. 33(2). 216–228. 65 indexed citations

Bouralexis, Stelios, David M. Findlay, Gerald J. Atkins, et al.. (2003). Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy. British Journal of Cancer. 89(1). 206–214. 54 indexed citations

Bouralexis, Stelios, et al.. (2002). Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanism. Journal of Endocrinology. 175(3). 715–725. 13 indexed citations

Atkins, Gerald J., Stelios Bouralexis, Andreas Evdokiou, et al.. (2002). Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis. Bone. 31(4). 448–456. 55 indexed citations

10.

Evdokiou, Andreas, Stelios Bouralexis, Gerald J. Atkins, et al.. (2002). Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to apo2l/trail‐induced apoptosis. International Journal of Cancer. 99(4). 491–504. 113 indexed citations

11.

Atkins, Gerald J., Stelios Bouralexis, David R. Haynes, et al.. (2001). Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone. Bone. 28(4). 370–377. 82 indexed citations

12.

Clayer, Mark, et al.. (2001). Enhanced Apoptosis of Soft Tissue Sarcoma Cells with Chemotherapy: A Potential New Approach Using Trail. Journal of orthopaedic surgery. 9(2). 19–22. 17 indexed citations

13.

Atkins, Gerald J., David R. Haynes, Stephen E. Graves, et al.. (2000). Expression of Osteoclast Differentiation Signals by Stromal Elements of Giant Cell Tumors. Journal of Bone and Mineral Research. 15(4). 640–649. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact